Want to see HK:2112 full AI Analyst Report?
Top Page
Grace Life-tech Holdings Limited
(2112)
Select Model
Select Model
Rating:41Neutral
Price Target:
HK$0.03
▼(-15.00% Downside)
Action:Upgraded
Date:06/30/26
The score is primarily driven by very weak financial performance: persistent losses, contracting revenue, negative shareholder equity, and generally negative operating/free cash flow materially increase funding and execution risk. With limited technical data available and a negative P/E (loss-making) alongside no dividend yield data, valuation and technical factors provide little support to offset the financial weakness.
Positive Factors
Improved 2025 Losses
Although still loss-making, 2025 profitability improved versus 2024, showing some progress in reducing annual losses. If sustained, this can moderate the pace of capital consumption and provide a base for eventual operating recovery, though the business remains far from breakeven.
Negative Factors
Persistent Losses and Revenue Contraction
Net losses persisted every year from 2020 through 2025, while revenue fell about 19% in 2025 after a steep 2023 decline. This combination signals an unstable top line and weak scale support, making a durable path to profitability difficult without sustained improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved 2025 Losses
Although still loss-making, 2025 profitability improved versus 2024, showing some progress in reducing annual losses. If sustained, this can moderate the pace of capital consumption and provide a base for eventual operating recovery, though the business remains far from breakeven.
Read all positive factors
Grace Life-tech Holdings Limited (2112) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$54.00M
Dividend Yield3.07%
Average Volume (3M)1.08M
Price to Earnings (P/E)―
Beta (1Y)0.48
Revenue Growth-45.65%
EPS Growth29.13%
CountryHK
Employees48
SectorBasic Materials
Sector Strength58
IndustryIndustrial - Distribution
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,500,000,000
10 Day Avg. Volume532,600
30 Day Avg. Volume1,083,600
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-0.06
Price to Sales (P/S)0.86
P/FCF Ratio-30.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Grace Life-tech Holdings Limited Business Overview & Revenue Model
Company Description
Grace Life-tech Holdings Limited, an investment holding company, engages in the research, development, and application of plant stem cell technology. It is also involved in the provision of health solutions and product sales in Hong Kong, the Peop...
Grace Life-tech Holdings Limited Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
8
Very Negative
Cash Flow
10
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.78M | 13.06M | 13.76M | 27.25M | 32.35M | 23.98M |
| Gross Profit | 1.18M | 1.48M | 2.17M | 2.85M | 2.54M | 164.00K |
| EBITDA | -7.96M | -7.50M | -30.49M | -23.74M | -42.55M | -44.21M |
| Net Income | -27.50M | -15.44M | -48.13M | -39.57M | -55.74M | -57.01M |
Balance Sheet | ||||||
| Total Assets | 77.60M | 75.50M | 79.80M | 108.95M | 133.56M | 173.13M |
| Cash, Cash Equivalents and Short-Term Investments | 129.98K | 358.95K | 255.00K | 135.00K | 187.00K | 1.19M |
| Total Debt | 161.26M | 148.27M | 193.26M | 121.04M | 171.57M | 166.50M |
| Total Liabilities | 271.23M | 257.10M | 247.29M | 228.85M | 213.88M | 197.41M |
| Stockholders Equity | -193.43M | -181.42M | -167.40M | -119.90M | -80.32M | -24.27M |
Cash Flow | ||||||
| Free Cash Flow | -4.43M | -372.55K | -78.00K | -53.00K | -1.01M | 1.10M |
| Operating Cash Flow | -4.43M | -372.55K | -75.00K | -27.00K | -1.00M | 1.41M |
| Investing Cash Flow | 0.00 | 0.00 | -3.00K | -26.00K | -2.00K | -303.00K |
| Financing Cash Flow | 4.48M | 488.72K | 193.00K | 0.00 | 0.00 | -12.00K |
Grace Life-tech Holdings Limited Technical Analysis
Neutral
0.04
Price Trends
0.04
Positive
0.05
Negative
0.06
Negative
Market Momentum
<0.01
Negative
52.48
Neutral
160.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2112, the sentiment is Neutral. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and below the 200-day MA of 0.06, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 52.48 is Neutral, neither overbought nor oversold. The STOCH value of 160.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2112.
Grace Life-tech Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
51 Neutral | HK$913.55M | 15.61 | 2.08% | 2.87% | 16.60% | -12.13% | |
45 Neutral | HK$384.07M | -15.78 | -329.69% | ― | 53.32% | ― | |
45 Neutral | HK$3.29B | -177.88 | -8.09% | 2.18% | 3.15% | 50.74% | |
41 Neutral | HK$54.00M | -0.25 | 14.68% | 3.07% | -45.65% | 29.13% |
* Basic Materials Sector Average
HK:2112
Grace Life-tech Holdings Limited
0.04
-0.02
-34.55%
HK:8189
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H
0.26
-0.18
-40.70%
HK:0609
Tiande Chemical Holdings Limited
1.04
-0.33
-24.25%
HK:0301
SANVO Fine Chemicals Group Limited
7.00
5.61
403.60%
HK:0660
Wai Chun Bio-Technology Ltd.
0.44
0.26
145.81%
HK:2565
PegBio Co., Ltd. Class H
5.81
-47.19
-89.04%
Grace Life-tech Holdings Limited Corporate Events
Grace Life-tech Publishes 2026 Interim Results Amid Ongoing Restructuring
Aug 31, 2026
Grace Life-tech Holdings Limited has released its unaudited interim results for the six months ended 30 June 2026, fulfilling Hong Kong listing requirements despite being under restructuring with joint provisional liquidators in place. The interim...
Grace Life-tech Sets August Board Meeting to Approve Interim Results and Consider Dividend
Aug 18, 2026
Grace Life-tech Holdings Limited has scheduled a board meeting for 31 August 2026 to review and approve the interim results of the company and its subsidiaries for the six months ended 30 June 2026. The board will also consider the declaration of ...
Grace Life-tech Shareholders Unanimously Back AGM Resolutions and Capital Mandates
Jun 16, 2026
Grace Life-tech Holdings Limited reported that all resolutions at its annual general meeting on 16 June 2026 were unanimously approved by shareholders voting by poll. The AGM received and adopted the 2025 audited financial statements, re-elected t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.